Chairpersons: 

• Prof. Dror Mevorach
• Dr. Shirly Oren

14:05 - 14:20 - Seroprevalence of SARS-CoV-2 Antibodies in Autoimmune Inflammatory Rheumatologic Patients

Tali Eviatar, David Levratovsky, Victoria Furer, Ari Polachek, Ofir Elalouf, Tami Halperin, Dan Turner, Daphna Paran, Sara Pel, Sharon Nevo, Ori Elkayam

14:20 - 14:35 - Covid19 among patients with autoimmune inflammatory rheumatic diseases (AIIRD) in Israel: the pattern of the pandemic, clinical characteristics and the impact on the AIIRD

Fadi Kharouf, Tali Eviatar, Maya Braun, Elisheva Pokroy-Shapira, Michal Brodavka, Nancy Agmon-Levine, Kochava Toledano, Shirly Oren, Merav Lidar, Yonit Tavor, Mirit Amit-Vazina, Firas Sabbach, Gabriel S. Breuer , Amir Dagan, Devy Zisman, Doron Markovits, Oshrat Tyer-Shifman, Tatiana Reitblatt, Samy Giries, Daphna Paran, Ori Elkayam, Dror Mevorach, Alexandra Balbir-Gurman and Yolanda Braun-Moscovici 

Chairpersons:

• Prof. Alexandra Balbir
• Prof. Howard Amital

14:35 - 14:50 - Suboptimal vaccination coverage with influenza, pneumococcal and herpes zoster vaccines among adult patients with autoimmune inflammatory rheumatic diseases in a nationwide health care plan

Victoria Furer, Clara Weil, Melanie Orin, Gabriel Chodick, Varda Shalev, Yonit Fisher-Shoval, Raanan Cohen, Ori Elkayam

14:50 - 15:05 - Influenza Vaccine Uptake among Patients with Juvenile Idiopathic Arthritis: A Multi-center Cross-sectional Study

Foteini Dasoula, Noa Alpert, Amit Ziv, Barbora Balažiová, M. Yildiz, Merav Heshin Bekenstein, Nataša Toplak, Yosef Uziel, for the PRES Vaccination Working Party

15:05 - 15:20 - Characteristics of interstitial lung disease in pts with systemic sclerosis during long-term follow-up, single center experience

Shiri Keret, Yolanda Braun-Moscovici, Doron Markovits, Adi Abshalom-Mashiah, Vika Shataylo, Samy Giries, Kochava Toledano, Yonit Tavor, Katya Dolnikov, Alexander Rozin, Mordehai Yigla, Luda Guralnik and Alexandra Balbir-Gurman

15:20 - 15:35 - Utilization of Healthcare Services and Drug Consumption in Fibromyalgia: A Cross-Sectional Analysis of the Clalit Health Service Database

Omer Gendelman, Raz Shapira, Shmuel Tiosano, Yuval Kuntzman, Avishai M Tsur, Aliza Hakimian, Doron Comanhester, Arnon D. Cohen, Dan Buskila, Howard Amital

Chairpersons:

• Prof. Daphna Paran
• Prof. Merav Lidar

15:45 - 16:00 - Update of Patient Advocacy Groups and  Announcement of Outstanding abstract winners

Mr. Rami Blass, Inbar patient association, Ms. Michal Nudel, Mifrakim Ze’irim patient association

16:00 - 16:20 - Outstanding clinical abstract: Humoral response to Pfizer mRNA vaccine against SARS CoV2, in patients with autoimmune inflammatory rheumatic diseases and the impact on the rheumatic disease activity

Yolanda Braun-Moscovici, Marielle Kaplan, Doron Markovits, Adi Abshalom-Mashiah, Vika Shataylo, Rita Erlich, Samy Giries, Kochava Toledano, Yonit Tavor, Katya Dolnikov, and Alexandra Balbir-Gurman

16:20 - 16:40 - Outstanding pediatric rheumatology abstract: A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity

Yonatan Butbul Aviel, Ayala Ofir, Ofer Ben-Izhak, Euvgeni Vlodavsky, Netanel Karbian, Riva Brik, Dror Mevorach, Daniella Magen

16:40 - 17:00 - Outstanding basic science abstract: Differential impact of biologics and glucocorticoids on TNF secretion and %CD14+CD16+ monocytes derived from synovial fluids of PsA patients in vitro

Smadar Gertel, Ari Polachek, Victoria Furer, David Levartovsky, Reut Tzemach, Katya Meridor, Dan Caspi and Ori Elkayam

17:00 - 17:45 - State of the Art Treatment of Behçet’s Syndrom

Prof. Gülen Hatemi - Istanbul University, Cerrahpaşa, Cerrahpaşa Medical School and Behçet’s Disease Research Center, Istanbul, Turkey

Chairpersons:

• Prof. Mahmoud Abu Shakra
• Dr. Muhammad Adawi

17:55 - 18:10 - The Functional Dexterity Test (FDT) measuring hand function correlates with overall disease activity in patients with rheumatoid arthritis

Amihai Levkoviz, Aniela Shouval, Itzhak Rosner, Irena Ruhkian, Boris Tchalabian, Gleb Slobodin

18:10 - 18:25 - Association between socioeconomic status and biologic treatment in patients with rheumatoid arthritis: a population-based cohort study

Ziv Paz, Fadi Hassan, Amir Saab, Haya Hussein, Avivit Golan Cohen, Eugene Merzon, Ilan Green and Mohammad E. Naffaa

18:25 - 18:40 - Tocilizumab (TCZ) decreases angiogenesis in Rheumatoid Arthritis through its regulatory effect on miR-146a-5p and EMMPRIN/CD147

Devy Zisman, Mirna Safieh, Elina Simanovich, Joy Feld, Amalia Kinarty, Liron Zisman, Tal Gazitt, Amir Haddad, Muna Elias, Itzhak Rosner, Lisa Kaly and Michal A. Rahat

18:40 - 18:55 - Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: A population-based cohort study

Mohammad E. Naffaa, Fadi Hassan, Avivit Golan Cohen, Eugene Merzon, Ilan Green, Amir Saab and Ziv Paz

18:55 - 19:10 - Switching from intravenous tocilizumab to subcutaneous administration during COVID19 pandemic – impact on treatment efficacy and patient satisfaction

Rula Daood, Kochava Toledano, Doron Markovits, Yonit Tavor, Samy Giries, Katya Dolnikov, Helani Jiries, Alexandra Balbir-Gurman and Yolanda Braun-Moscovici

Chairpersons:

• Prof. Gabriel Breuer
• Dr. Hagit Peleg

19:20 - 19:35 - Tocilizumab treatment in giant cell arteritis in real world clinical practice: Observational, monocenter study of 34 patients

Ariela Dortort Lazar, Yair Molad

19:35 - 19:50 - Von – Willebrand factor, a possible marker for disease activity in vasculitis

Doron Rimar, Jomana Mazareeb, Abid Awisat, Itzhak Rosner, Michael Rozenbaum, Lisa Kaly, Gleb Slobodin

19:50 - 20:05 - IgG4-related disease in Israel: A retrospective, single-center cohort

Elisheva Pokroy-Shapira, Iftach Sagy, Katya Meridor and Yair Molad

20:05 - 20:20 - Henoch–Schonlein purpura in Adults, pediatric, and non-vasculitic IGA nephropathy

Amir Bieber, Shirel Levanon, Vera Gotloieb, Yehudit Kraus, Irina Novofastovski, Abdallah Fawaz, Muhammad Aghbariyya, Reuven Mader

Chairpersons:

• Prof. Reuven Mader
• Prof. Gleb Slobodin

8:00 - 8:15 - The diagnostic utility of serum interleukin-22 in patients with suspected axial spondyloarthritis

Sagiv M, Adawi M, Awisat A, Shouval A, Peri R, Sabbah F, Rosner I, Kessel A, Slobodin G

8:15 - 8:30 - Magnetic resonance imaging in high risk patients for the development of diffuse idiopathic skeletal hyperostosis (DISH)-a preliminary report

Reuven Mader, Iris Eshed, Irina Novofastovski, Abdallah Fuaz, Amir Bieber

8:30 - 8:45 - Improvement in the diagnostic delay of axial spondyloarthritis, results from real world data

Joy Feld, Ori Elkayam, Amit Druyan, Tatiana Reinblat, Alexandra Balbir-Gurman, Amir Haddad, Tal Gazitt, Muna Elias, Victoria Furer, Tania Mashiach, Devy Zisman

8:45 - 9:30 - The enigma of ankylosis in axial spondyloarthritis revisited

Prof. Dr. Rik Lories, MD, PhD - Full Professor at KU Leuven, Head of Department Development and Regeneration - KU Leuven
Director Skeletal Biology and Engineering Research Centre
Co-director Laboratory Tissue Homeostasis and Disease -“Lories & Monteagudo” Lab

Chairpersons:

• Prof. Ori Elkayam
• Dr. Devy Zisman

9:40 - 9:55 - Treatment with ixekizumab following secukinumab failure in patients with psoriatic arthritis: real-life experience from a resistant population

Julia Berman, Victoria Furer, Mark Berman, Ofer Isakov, Devy Zisman, Amir Haddad, Ori Elkayam

9:55 - 10:10 - Reduced LAG-3+ T cells are restored by TNF inhibitors in PBMCs derived from active PsA patients in vitro

Smadar Gertel, Ari Polachek, Victoria Furer, David Levartovsky and Ori Elkayam

10:10 - 10:25 - Analysis of venous thromboembolic risk among psoriatic arthritis patients

Tal Gazitt, Jacob Pesachov, Idit Lavi, Muna Elias, Amir Haddad, Ilan Feldhamer, Arnon Dov Cohen, Walid Saliba and Devy Zisman

10:25 - 10:40 - The Association of Psoriatic Arthritis with All-Cause Mortality and Leading Causes of Death in Psoriatic Arthritis

Amir Haddad, Walid Saliba, Idit Lavi, Amin Batheesh, Samir Kasem, Tal Gazitt, Ilan Feldhamer, Arnon Dov Cohen, Devy Zisman

10:40 - 10:55 - Cholinergic dysregulation in patients with psoriatic arthritis

Hila Nochomovitz, Victoria Furer, Shlomo Berliner, Ori Elkayam, Ori Rogovsky, Shani Shenhar-Tzarfaty equal contribution

Chairpersons:

• Prof. Yair Molad
•  Prof. Shay Kivity

11:20 - 11:35 - Increased prevalence of obstructive sleep apnea in individuals with systemic lupus erythematosus

Roni Meidan, Daphna Paran, David Levartovsky, Victoria Furer, Ari Polachek, Jonathan Wollman, Hagit Padova, Tali Eviatar, Michael Zisapel, Marina Anuk, Riva Tauman, Estelle Seyman, Ori Elkayam, Ofir Elalouf

11:35 - 11:50 - Cardiac valve surgery outcomes in the antiphospholipid syndrome

Tali Eviatar, Stanley Niznik, Nancy Agmon- Levin, Daphna Paran

11:50 - 12:05 - Fracture risk in systemic lupus erythematosus patients over 28 years

Daniela Garelick, Sara Moreira Pinto, Filipa Farinha, Tatiana Pires, Emon Khan, David Isenberg

12:05 - 12:20 - Performance of 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a pediatric population - a multicenter study

Yoel Levinsky, Mor Broide, Shelly Kagan, Ori Goldberg, Oded Scheuerman, Rotem Tal, Irit Tirosh, Yonatan Butbul Aviel, Liora Harel, Gil Amarilyo

12:20 - 12:35 - Brain imaging patterns and blood brain barrier integrity in patients with SLE

Shiran Aharon, Dafna Ben- Bashat, Victoria Furer, Marina Anouk, Yael Lahat, Mark Berman, Jonathan Wollman, Ofir Elalouf, Ari Polachek, Daphna Paran